Samuel Sanchez given backdated two-year doping ban


Spanish cyclist Samuel Sanchez has been handed a backdated two-year doping ban for an anti-doping rule violation committed on 9 August 2017.

The 2008 Olympic Gold road race champion has been on a provisional suspension since he returned the positive result for the growth hormone GHRP-2 in an out of competition test in 2017.

Following a near two-year investigation, the Union Cycliste Internationale (UCI) confirmed that the review revealed the likelihood of the origin of the ADRV was a contaminated supplement that Mr Sanchez had been using.

The UCI stated ‘While the UCI would have preferred the case to be resolved sooner, establishing the source of the ADRV required multiple scientific analyses, as well as follow-up investigations, to make sure the correct conclusions were reached.’

As a result, Sanchez was sanctioned with a period of ineligibility of two years which will be backdated from the start of his provisional suspension. He can return to cycling on 16 August 2019.

You may also like

View All

IOC to take over gender eligibility criteria previously managed by international federations

The new leader of the International Olympic Committee, Kirsty Coventry, has announced that the committee will take over responsibility of gender eligibility criteria, acknowledging concerns about leaving the issue solely to international federations

Read More

Faith Kipyegon sparks discussion on sport integrity as she attempts to break the four-minute mile barrier using new, unapproved technology

Kenyan middle-to-long distance runner, Faith Kipyegon, is attempting to be the first woman to run a mile in under four minutes with the help of new, unapproved technology, sparking discussion on sport integrity and accessibility

Read More

World Athletics has established a Request for Proposal concerning shoe regulations

World Athletics has established a Request for Proposal covering two services that concern its athlete shoe regulations

Read More

Newsletter Signup

Please enter your email address below: